TRICARE Pharmacy Program RFI (Draft Section C & H)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
-
NAICS
524114 - Direct Health and Medical Insurance Carriers
Classification Code
Q201
Additional Details
Documents3
The Defense Health Agency (DHA), operating under the Department of Defense, has issued a Special Notice as part of its acquisition planning for the forthcoming TRICARE Pharmacy Program (TPharm6) contract. This notice serves as a Request for Information (RFI) and is specifically aimed at soliciting industry feedback on two critical draft documents: Section C (Statement of Work) and Section H (Special Contract Requirements). The intent is to refine and enhance the program’s requirements and contractual framework prior to formal solicitation.
The TPharm6 contract represents the next generation of the TRICARE Pharmacy Program, a cornerstone initiative designed to ensure comprehensive pharmacy benefits for eligible Department of Defense beneficiaries. The scope of this procurement is expected to encompass the administration and management of pharmacy benefits, aligning with the NAICS code 524114 (Direct Health and Medical Insurance Carriers) and Product Service Code Q201, which pertains to medical services. The place of performance is within the United States.
DHA is seeking input from qualified vendors with relevant experience in large-scale health and pharmacy benefit management. The agency has made available draft versions of the Statement of Work and Special Contract Requirements to facilitate transparent communication and to incorporate industry best practices and innovative solutions. Contractors are encouraged to review these documents thoroughly and provide substantive feedback, questions, or recommendations that could inform the final solicitation.
To foster a collaborative environment, DHA will host one-on-one meetings with interested vendors during the summer of 2026. These sessions are intended to provide a forum for direct dialogue, clarification of requirements, and deeper exploration of industry perspectives. Vendors wishing to participate must submit their requests via the provided online form by May 11, 2026, 12:00 PM Mountain Time. Similarly, all written comments and questions regarding the draft documents must be submitted by the same deadline to [email protected], with the company name and “Draft Documents Response” in the subject line.
The contracting entity for this opportunity is the Defense Health Agency, a federal office within the Department of Defense. The primary points of contact for this notice are Viktoria Reed ([email protected], 303-676-3648) and Brooke Wolfe ([email protected], 303-676-3799), who can provide additional information or clarification as needed.
This RFI does not constitute a formal solicitation, nor does it commit the government to any contractual obligations at this stage. Rather, it is a critical step in shaping the future TPharm6 contract to ensure it meets the evolving needs of the TRICARE beneficiary population and leverages industry expertise. Contractors with capabilities in direct health and medical insurance administration, particularly those with experience in federal healthcare programs, are strongly encouraged to engage in this process.
Further details, including the draft documents and instructions for participation, are available on the official SAM.gov opportunity page (https://sam.gov/opp/a05cf75c0f2640619ac7bc41221cc4c6/view). This notice remains active, and interested parties should adhere to the specified submission deadlines to ensure their input is considered in the program’s development.